已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay

药理学 药代动力学 肾脏疾病 药物代谢 药品 医学 肝功能不全 内科学
作者
Yi‐An Bi,Samantha Jordan,Amanda King‐Ahmad,Mark A. West,Manthena V. S. Varma
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:115 (6): 1336-1345 被引量:5
标识
DOI:10.1002/cpt.3215
摘要

Daprodustat is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor approved recently for the treatment of anemia caused by chronic kidney disease (CKD) in adults receiving dialysis. We evaluated the role of organic anion transporting polypeptide (OATP)1B-mediated hepatic uptake transport in the pharmacokinetics (PKs) of daprodustat using in vitro and in vivo studies, and physiologically-based PK (PBPK) modeling of its drug-drug interactions (DDIs) with inhibitor drugs. In vitro, daprodustat showed specific transport by OATP1B1/1B3 in the transfected cell systems and primary human and monkey hepatocytes. A single-dose oral rifampin (OATP1B inhibitor) reduced daprodustat intravenous clearance by a notable 9.9 ± 1.2-fold (P < 0.05) in cynomolgus monkeys. Correspondingly, volume of distribution at steady-state was also reduced by 5.0 ± 1.1-fold, whereas the half-life change was minimal (1.5-fold), corroborating daprodustat hepatic uptake inhibition by rifampin. A PBPK model accounting for OATP1B-CYP2C8 interplay was developed, which well described daprodustat PK and DDIs with gemfibrozil (CYP2C8 and OATP1B inhibitor) and trimethoprim (weak CYP2C8 inhibitor) within 25% error of the observed data in healthy subjects. About 18-fold increase in daprodustat area under the curve (AUC) following gemfibrozil treatment was found to be associated with strong CYP2C8 inhibition and moderate OATP1B inhibition. Moreover, PK modulation in hepatic dysfunction and subjects with CKD, in comparison to healthy control, was well-captured by the model. CYP2C8 and/or OATP1B inhibitor drugs (e.g., gemfibrozil, clopidogrel, rifampin, and cyclosporine) were predicted to perpetrate moderate-to-strong DDIs in healthy subjects, as well as, in target CKD population. Daprodustat can be used as a sensitive CYP2C8 index substrate in the absence of OATP1B modulation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
子凯完成签到,获得积分10
1秒前
枕边人完成签到 ,获得积分10
1秒前
pandary发布了新的文献求助10
2秒前
2秒前
英姑应助u9227采纳,获得10
3秒前
3秒前
共享精神应助科研通管家采纳,获得10
4秒前
深情安青应助L同学采纳,获得30
4秒前
科研通AI6应助科研通管家采纳,获得30
4秒前
NexusExplorer应助lzl17o8采纳,获得10
4秒前
8R60d8应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
ccm应助科研通管家采纳,获得10
4秒前
orixero应助科研通管家采纳,获得10
4秒前
李健应助科研通管家采纳,获得10
4秒前
4秒前
JamesPei应助科研通管家采纳,获得10
4秒前
GPTea应助科研通管家采纳,获得20
5秒前
浮游应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
FashionBoy应助淡定沧海采纳,获得10
5秒前
溜达鸡完成签到 ,获得积分10
6秒前
GD发布了新的文献求助10
7秒前
假茂茂发布了新的文献求助10
8秒前
10秒前
10秒前
Lucas应助英勇羿采纳,获得30
11秒前
12秒前
满意白卉完成签到 ,获得积分10
13秒前
u9227发布了新的文献求助10
16秒前
量子星尘发布了新的文献求助10
16秒前
17秒前
YXHTCM发布了新的文献求助10
17秒前
455完成签到,获得积分10
18秒前
18秒前
小鱼完成签到 ,获得积分10
21秒前
慕青应助菠萝披萨采纳,获得10
22秒前
九思发布了新的文献求助10
23秒前
林牧完成签到,获得积分10
25秒前
高分求助中
Aerospace Standards Index - 2025 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Video: Lagrangian coherent structures in the flow field of a fluidic oscillator 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
Teaching Language in Context (Third Edition) 1000
List of 1,091 Public Pension Profiles by Region 961
流动的新传统主义与新生代农民工的劳动力再生产模式变迁 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5449302
求助须知:如何正确求助?哪些是违规求助? 4557480
关于积分的说明 14263669
捐赠科研通 4480533
什么是DOI,文献DOI怎么找? 2454467
邀请新用户注册赠送积分活动 1445212
关于科研通互助平台的介绍 1420986